Publications

Dashtipour, K, F Gupta, RA Hauser, CA Krunapuzha, and JC Morgan. 2021. “Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice. Parkinsons Dis 2021:2603641. Doi: 10.1155/2021/2603641.”. Parkinsons Dis.

Hauser, RA, L Zeitlin, S Fisher, and R D’Souza. 2021. “Duration of Benefit Per Dose: Carbidopa-Levodopa Immediate Release Vs. Extended Release Capsules (Rytary®). Parkinsonism Relat Disord 2021;82:133-137.”. Parkonsonism Relat Disord.

Simuni, T, B Fiske, K Merchant, CS Coffey, E Klingner, C Caspell-Garcia, DE Lafontant, et al. 2021. “Parkinson Study Group NILO-PD Investigators and Collaborators (including Hauser RA). Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol 2021;78:312-320.”. JAMA Neurol.

LeWitt, PA, SD Aradi, RA Hauser, and O Rascol. 2020. “The Challenge of Developing Adenosine A2A antagonists for Parkinson Disease: Istradefylline, Preladenant, and Tozadenant. Parkinsonism Relat Disord 2020;80 Suppl 1:S54-S63.”. Parkinsonism Relat Disord.

Hauser, RA, JM Meyer, SA Factor, CL Comella, CM Tanner, RM Xavier, SN Caroff, and L Lundt. 2020. “Differentiating Tardive Dyskinesia: A Video-Based Review of Antipsychotic-Induced Movement Disorders in Clinical Practice. CNS Spectr 2020;20:1-10.”. CNS Spectr.

Farbman, ES, CH Waters, PA LeWitt, M Rudinska, M Klingler, A Lee, J Qian, C Oh, and RA Hauser. 2020. “A 12-Month, Dose-Level Blinded Safety and Efficacy Study of Levodopa Inhalation Powder (CVT-301, Inbrija) in Patients With Parkinson’s Disease. Parkinsonism Relat Disord 2020;81:144-150.”. Parkinsonism Relat Disord.

Hauser, RA, and . 2020. “Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies. Front Neurol. 2020;11:576117.”. Front Neurol.

Mills, KA, RB Schneider, M Saint-Hilaire, GW Ross, RA Hauser, AE Lang, MJ Halverson, et al. 2020. “Cognitive Impairment in Parkinson’s Disease: Associations Between Subjective and Objective Cognitive Decline in a Large Longitudinal Study. Parkinsonism Relat Disord 2020;80:127-132.”. Parkinsonism Relat Disord.

Bhidayasiri, R, JM Kane, KP Frei, SN Caroff, CU Correll, S Fahn, J Jankovic, RA Hauser, and DD Truong. 2020. “Expanding Phenomenologic Heterogeneity of Tardive Syndromes: Time for an Updated Assessment Tool. Parkinsonism Relat Disord 2020;77:141-145.”. Parkonsonism Relat Disord.

Aradi, SD, and RA Hauser. 2020. “Medical Management and Prevention of Motor Complications in Parkinson’s Disease. Neurotherapeutics 2020;17:1339-1365.”. Neurotherapeutics.